Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Casi Pharmaceuticals Inc (CASI)

Casi Pharmaceuticals Inc (CASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Casi Pharmaceuticals Inc 1701-1702 China Central Office Tower 1 No. 81 Jianguo Road Chaoyang District Beijing F4 100025 CHN

www.casipharmaceuticals.com Employees: 233 P: 86-10-6508-6063

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. CASI Pharmaceuticals Inc., formerly known as EntreMed, Inc., is headquartered in Rockville, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 9,618
Enterprise Value, $K 14,538
Shares Outstanding, K 12,299
Annual Sales, $ 28,540 K
Annual Net Income, $ -39,260 K
Last Quarter Sales, $ 3,080 K
Last Quarter Net Income, $ -10,880 K
EBIT, $ -44,410 K
EBITDA, $ -42,080 K
60-Month Beta 0.90
% of Insider Shareholders 21.24%
% of Institutional Shareholders 22.23%
Float, K 9,687
% Float 78.76%
Short Interest 101
Short Float 0.82%
Short Volume Ratio 0.17

Growth:

1-Year Return -72.27%
3-Year Return -56.31%
5-Year Return -97.35%
5-Year Revenue Growth 591.04%
5-Year Earnings Growth 39.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.67 on 11/14/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -3.01
EPS Growth vs. Prev Qtr 22.09%
EPS Growth vs. Prev Year -21.82%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 06/02/22

CASI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -131.54%
Profit Margin % -137.56%
Debt/Equity -0.66
Price/Sales 0.32
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.32
Interest Coverage -42.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar